ARTICLE | Company News
bioMerieux, GlaxoSmithKline deal
November 23, 2009 8:00 AM UTC
GlaxoSmithKline will co-fund bioMerieux's development of a pharmacogenetic test using undisclosed biomarkers for cancer. The CLIA test initially will be marketed by bioMerieux's bioTheranostics Inc. s...